Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 45,930 | 90,559 | 41,283 | 28,520 | 20,865 |
| Gross Profit | 45,930 | 90,559 | 41,283 | 28,520 | 20,865 |
| Operating Expenses | 70,428 | 75,949 | 65,459 | 50,656 | 65,837 |
| Operating Income | -24,498 | 14,610 | -24,176 | -22,136 | -44,972 |
| Other Income | 1,080 | 914 | 1,042 | 618 | 429 |
| Pre-tax Income | -23,418 | 15,524 | -23,134 | -21,518 | -44,543 |
| Net Income Continuous | -23,418 | 15,524 | -23,134 | -21,518 | -44,543 |
| Net Income | $-23,418 | $15,524 | $-23,134 | $-21,518 | $-44,543 |
| EPS Basic Total Ops | -0.48 | 0.48 | -0.49 | -0.53 | -1.15 |
| EPS Basic Continuous Ops | -0.48 | 0.48 | -0.49 | -0.53 | -1.15 |
| EPS Diluted Total Ops | -0.48 | 0.48 | -0.49 | -0.53 | -1.15 |
| EPS Diluted Continuous Ops | -0.48 | 0.48 | -0.49 | -0.53 | -1.15 |
| EBITDA(a) | $-24,359 | $14,874 | $-23,855 | $-21,820 | $-44,646 |